465 results on '"Yossepowitch, Ofer"'
Search Results
2. Mini-HoLEP (MILEP) vs HoLEP: a propensity score-matched analysis
3. Assessing the Impact of Percutaneous Nephrostomy Presence on Neoadjuvant Treatment Quality in Patients With Muscle Invasive Bladder Cancer
4. En bloc holmium laser enucleation of prostate in octogenarians and nonagenarians: clinical characteristics and outcome
5. The role of serum and urinary markers in predicting obstructing ureteral stones and reducing unjustified non-contrast computerized tomographic scans in emergency departments
6. 11-item modified frailty index and outcomes after radical cystectomy
7. Natural history and health care burden of non-curative treatment for muscle-invasive bladder cancer
8. Querying the significance of patient position during computerized tomography on the reliability of pre-percutaneous nephrolithotomy planning
9. Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement
10. Current Role of PET CT in Staging and Management of Penile Cancers.
11. Preoperative 68Ga-PSMA PET/CT defines a subgroup of high-risk prostate cancer patients with favorable outcomes after radical prostatectomy and lymph node dissection
12. The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0
13. Diagnostic Needle Biopsies in Renal Masses: Patient and Physician Perspectives
14. Predictors of surgical site infection after radical cystectomy: should we enhance surgical antibiotic prophylaxis?
15. The effect of delaying transperineal fusion biopsy of the prostate for patients with suspicious MRI findings—Implications for the COVID-19 era
16. [68Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up?
17. Complete Blood Count Markers and C-Reactive Protein as Predictors of Testicular Viability in the Event of Testicular Torsion in Adults.
18. Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study.
19. Staging Prostate Cancer with 68Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
20. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma
21. A Novel Urine Cytology Stain for the Detection and Monitoring of Bladder Cancer
22. Long-Term Indwelling Tandem Polymeric Ureteral Stents for Benign Ureteral Obstruction.
23. External validation of a simplified prognostic model for survival in patients with extrinsic malignant ureteral obstruction treated with tandem ureteral stents – a retrospective cohort study.
24. The oncologic role of local treatment in primary metastatic prostate cancer
25. An Ileal Conduit—Who Takes Care of the Stoma?
26. Urothelial Carcinoma of the Bladder in Patients on Hemodialysis: Clinical Characteristics and Oncological Outcomes
27. External Validation of a Biomarker Based Pre-Cystectomy Algorithm to Predict Nonorgan Confined Urothelial Cancers
28. Testicular Prostheses for Testis Cancer Survivors: Patient Perspectives and Predictors of Long-Term Satisfaction
29. COLOR AND MORPHOLOGY COMBINATION FOR DETECTION OF LOW-GRADE UROTHELIAL CANCER CELLS: MULTI-CENTER VALIDATION STUDY: PD11-08
30. Introducing in clinical practice a new laser suction handpiece for percutaneous nephrolithotomy.
31. Improving Prostatic Preoperative Volume Estimation and Planning before Laser Enucleation.
32. Association between early change in neutrophil‐to‐lymphocyte ratio after radical cystectomy and treatment outcomes.
33. PD23-03 A NOVEL URINE CYTOLOGY STAIN FOR THE DETECTION AND MONITORING OF UROTHELIAL CARCINOMA
34. PD17-12 PATIENT COMPLIANCE WITH INTRAVESICAL MAINTENANCE PROTOCOLS FOR NON-MUSCLE INVASIVE BLADDER CANCER
35. PD11-12 URINARY TRACT INFECTION AFTER URINARY DIVERSION – DIFFERENT PATTERNS OF OCCURRENCE IN PATIENTS WITH ILEAL CONDUIT AND ORTHOTOPIC NEOBLADDER
36. Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey
37. Holmium Laser Endoureterotomy for Benign Ureteral Stricture: A Single Center Experience
38. Impact of COVID‐19 pandemic on patients with obstructing urinary stones complicated by infection.
39. Low-dose oral desmopressin for treatment of nocturia and nocturnal enuresis in patients after radical cystectomy and orthotopic urinary diversion
40. Secondary Therapy, Metastatic Progression, and Cancer-Specific Mortality in Men with Clinically High-Risk Prostate Cancer Treated with Radical Prostatectomy
41. Relationship of Prostate-Specific Antigen Velocity to Histologic Findings in a Prostate Cancer Screening Program
42. CURRENT TRENDS IN MANAGEMENT OF HIGH-RISK PROSTATE CANCER IN EUROPE: RESULTS OF A WEB-BASED SURVEY BY THE PROSTATE CANCER WORKING GROUP OF THE YOUNG ACADEMIC UROLOGISTS WORKING PARTY OF THE EUROPEAN ASSOCIATION OF UROLOGY: PD14-10
43. Role of radical prostatectomy in the treatment of high-risk prostate cancer
44. Radical prostatectomy for high-risk prostate cancer
45. Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement.
46. Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trial
47. Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors
48. Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients
49. The Natural History of Noncastrate Metastatic Prostate Cancer after Radical Prostatectomy
50. Low risk prostate cancer in men under age 65: The case for definitive treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.